Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

Obermair called for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Climate Asset Management has raised more than $1 billion to invest in natural capital projects such as regenerative agriculture, its chief executive told Reuters.

Household confidence has sunk as concerns grow that Rachel Reeves and Sir Keir Starmer are talking Britain into a downturn.

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

GSK PLC GSK shares slipped 1.84% to £15.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.72. Supported ...